Chromatrap's solid-state ChIP technology has been selected by US-firm BioLegend to power a new range of faster and more efficient chromatin immunoprecipitation kits.
The new kits will combine BioLegend's expertise in developing the Go-ChIP-Grade antibodies that are validated for ChIP assays with the patented solid-state immunocapture surface at the heart of every Chromatrap product. The resulting kits are aimed at offering researchers an opportunity to perform faster, simpler and more sensitive assays for their epigenetics research.
Dr Amy Beynon, Product Development Manager for Chromatrap, said "The wide distribution network offered by BioLegend is an ideal way to expand the reach of our proven novel solid-state ChIP technology. Access to important geographical markets
where BioLegend is an established and trusted supplier forms the core of our relationship. We look forward to supporting many more researchers as BioLegend expands the usage of Chromatrap technology across these markets."
The Chromatrap technology is patented in the USA, Australia, Japan, UK and China by parent company - Porvair. The collaboration with BioLegend covers access to Chromatrap spin columns and proprietary buffers for use in BioLegend's new
ChIP-sequencing kits in all geographic territories.
